DERENZINI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 2.768
EU - Europa 1.886
AS - Asia 755
AF - Africa 137
SA - Sud America 10
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.561
Nazione #
US - Stati Uniti d'America 2.759
GB - Regno Unito 493
CN - Cina 314
SE - Svezia 288
IT - Italia 280
DE - Germania 226
UA - Ucraina 149
VN - Vietnam 149
SG - Singapore 143
IN - India 95
IE - Irlanda 88
CH - Svizzera 82
FR - Francia 68
TG - Togo 68
RU - Federazione Russa 64
ZA - Sudafrica 39
EE - Estonia 33
HR - Croazia 27
JO - Giordania 26
BG - Bulgaria 17
BE - Belgio 15
AT - Austria 13
CI - Costa d'Avorio 11
JP - Giappone 11
NG - Nigeria 10
PL - Polonia 10
CA - Canada 9
SC - Seychelles 9
GR - Grecia 8
FI - Finlandia 7
NL - Olanda 6
CZ - Repubblica Ceca 5
BR - Brasile 4
CO - Colombia 4
AU - Australia 3
IR - Iran 3
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
HK - Hong Kong 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
DK - Danimarca 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
RO - Romania 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.561
Città #
Southend 440
Fairfield 360
Chandler 303
Ashburn 212
Ann Arbor 189
Woodbridge 170
Wilmington 169
Houston 166
Seattle 154
Cambridge 131
Singapore 125
Jacksonville 105
Princeton 100
Dublin 88
Bern 79
Bologna 71
Dong Ket 70
Lomé 68
Nanjing 47
Padova 47
Westminster 46
Shenyang 27
Amman 26
Berlin 26
Jinan 25
New York 24
Santa Clara 24
Redwood City 23
Nanchang 22
Saint Petersburg 22
Beijing 21
Los Angeles 21
Turin 21
Hebei 20
San Diego 18
Boardman 17
Mülheim 17
Sofia 17
Milan 16
Brussels 15
Verona 13
Florence 12
Tianjin 12
Abidjan 11
Haikou 11
Abeokuta 10
Bremen 10
Changsha 10
Olalla 10
Vienna 10
Hyderabad 9
Jiaxing 9
Mahé 9
Ningbo 9
Tokyo 8
Zhengzhou 8
Guangzhou 7
Helsinki 7
London 7
Medford 7
Mountain View 7
Sherbrooke 7
Fuzhou 6
Leawood 6
Shanghai 6
Taiyuan 6
Zola Predosa 6
Dallas 5
Des Moines 5
Hefei 5
Lanzhou 5
Norwalk 5
San Venanzo 5
Wayne 5
Amsterdam 4
Barranquilla 4
Dearborn 4
Falls Church 4
Hangzhou 4
Kuban 4
São Paulo 4
Warsaw 4
Boydton 3
Bratislava 3
Chicago 3
Modena 3
Redmond 3
Rome 3
Taizhou 3
Andover 2
Athens 2
Bochum 2
Canberra 2
Casalecchio di Reno 2
Clearwater 2
Frankfurt Am Main 2
Hanover 2
Harbin 2
Lagaro 2
Monmouth Junction 2
Totale 3.885
Nome #
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 213
CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS 176
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. 164
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 156
Erosions or not in GORD? The potential role of oesophageal cell proliferation 153
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53- deficient and proficient human osteosarcoma cell lines. 153
Liver targeted doxorubicin: effects on rat regenerating hepatocytes. 151
Location of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes. 147
Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. 145
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 145
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 144
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells 136
Endoscopic appearance of GERD: Putative role of cell proliferation 135
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. 133
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 132
The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition 132
Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: a prospective study on patients with HCV related cirrhosis. 132
Esophageal cell proliferation in gastroesophageal reflux disease: clinical-morphological data before and after pantoprazole. 131
The Ribosome Biogenesis-Cancer Connection 131
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. 128
Hyperoxia fully protects mitochondria of explanted livers 127
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. 127
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 122
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. 118
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 117
Relationship between dyskerin expression and telomerase activity in human breast cancer. 114
Relationship between the RB1 mRNA level and the expression of phosphorylated RB protein in human breast cancers: their relevance in cell proliferation activity and patient clinical outcome 111
Prognostic relevance of a novel semi-quantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. 111
Structural and functional organization of ribosomal genes within the mammalian cell nucleolus 110
Erosions or not in GERD? The potential role of esophageal cell kinetics 103
Nucleolar size and activity are related to pRb and p53 status in human breast cancer 102
null 101
Nucleolus, ribosomes, and cancer. 100
The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status 100
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. 99
Cell proliferation in breast cancer: a major determinant of clinical outcome in node-positive, but not in node-negative patients. 98
Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer 97
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. 96
Mathematical model predicting high hepatocyte proliferation index and risk of HCC in patients with HCV related cirrhosis: a proposal for clinical validation 96
Targeted cancer therapy with ribosome biogenesis inhibitors: A real possibility? 96
What the nucleolus says to a tumour pathologist. 90
Wnt system and differentiation in medulloblastoma cell lines 88
The effect of FSH and NAC on human cryopreserved ovarian tissue cultured for 32 weeks 81
null 81
null 69
The effect of IGF II on human cryopreserved ovarian tissue in long-term cultures 65
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate 57
Ribosome biogenesis and control of cell proliferation: p53 is not alone. 32
Ribosome biogenesis and cancer 20
Ischemia-reperfusion injury in rat fatty liver: Role of nutritional status 19
Chromatin structure in situ: the contribution of DNA ultrastructural cytochemistry. 11
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 6
Primary endocervical extraosseous Ewing's sarcoma/PNET 6
Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis 6
Totale 5.713
Categoria #
all - tutte 14.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.020


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.268 0 0 24 87 145 148 195 202 214 102 65 86
2020/2021843 156 57 17 48 25 103 18 46 87 51 49 186
2021/20221.067 103 22 70 135 83 48 21 70 20 98 243 154
2022/20231.224 95 187 62 153 71 93 52 79 214 16 88 114
2023/2024259 27 38 10 38 21 54 12 17 8 14 13 7
2024/2025309 54 180 75 0 0 0 0 0 0 0 0 0
Totale 5.713